Speaker: Sharareh Eskandarieh, Assistant Professor, Tehran University of Medical Sciences
What key insights will you be sharing in your session?
Sharareh Eskandarieh: Greetings! I will share an epidemiological view of regional similarities and differences in MS comorbidities, and report comorbidity patterns and the prevalence of values comorbidities in MS by systematic review. A multidisciplinary approach and timely recognition of comorbidities are principles to starting effective treatment in persons with MS. So, a clear understanding of regional conditions and comorbidity prevalence in established MS populations is needed. Therefore, understanding these risk factors for developing such diseases and how this might affect MS progression is critical for individualised treatment that could improve outcomes of persons with MS.
Why is MSMilan2023 such an important event for MS experts and neurologists?
Sharareh Eskandarieh: ECTRIMS usually plays an important role in the current medical education of healthcare professionals. By attending MSMilan2023, you can get the latest information on MS research and treatment improvement. MSMilan2023 will be abundant in the latest science innovation of MS treatments and research, management of disease, and diagnosis. MSMilan2023 brings a chance to network with colleagues. Different professionals come from near and far to attend this congress, making it a great opportunity for networking with others from the MS scientific community. Hope to meet you at ECTRIMS 2023.
